SOLTF
Price:
$7.75
Market Cap:
$106.22B
Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboratio...[Read more]
Industry
Biotechnology
IPO Date
2013-09-04
Stock Exchange
PNK
Ticker
SOLTF
According to Sosei Group Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -28.70. This represents a change of -41.15% compared to the average of -48.77 of the last 4 quarters.
The mean historical PE Ratio of Sosei Group Corporation over the last ten years is 73.12. The current -28.70 PE Ratio has changed -4024.93% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's PE Ratio was at its highest in in the December 2016 quarter at 11.19K. The PE Ratio was at its lowest in in the September 2015 quarter at -1699.58.
Average
73.12
Median
101.93
Minimum
-647.85
Maximum
590.60
Discovering the peaks and valleys of Sosei Group Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 325.76%
Maximum Annual PE Ratio = 590.60
Minimum Annual Increase = -235.50%
Minimum Annual PE Ratio = -647.85
Year | PE Ratio | Change |
---|---|---|
2023 | -16.17 | -105.07% |
2022 | 318.86 | 103.31% |
2021 | 156.83 | 80.69% |
2020 | 86.79 | -25.85% |
2019 | 117.06 | -235.50% |
2018 | -86.39 | -218.72% |
2017 | 72.77 | -111.23% |
2016 | -647.85 | -209.69% |
2015 | 590.60 | 325.76% |
2014 | 138.72 | -147.68% |
The current PE Ratio of Sosei Group Corporation (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
153.17
5-year avg
132.67
10-year avg
73.12
Sosei Group Corporation’s PE Ratio is less than Gain Therapeutics, Inc. (-1.84), less than BioVie Inc. (-0.34), less than IN8bio, Inc. (-0.43), less than NewAmsterdam Pharma Company N.V. (-7.41), less than Cue Biopharma, Inc. (-1.59), less than uniQure N.V. (-0.95), less than Rocket Pharmaceuticals, Inc. (-6.23), less than Rhythm Pharmaceuticals, Inc. (-12.46), less than Solid Biosciences Inc. (-2.55), less than MeiraGTx Holdings plc (-4.12), less than Apellis Pharmaceuticals, Inc. (-10.63), greater than Blueprint Medicines Corporation (-45.48), greater than Karuna Therapeutics, Inc. (-29.52), less than Mirati Therapeutics, Inc. (-5.32), less than Day One Biopharmaceuticals, Inc. (-17.12), less than VectivBio Holding AG (-7.94), less than AVROBIO, Inc. (2.07), less than Zura Bio Limited (-10.87), less than Elevation Oncology, Inc. (-0.78), less than Hepion Pharmaceuticals, Inc. (-0.13),
Company | PE Ratio | Market cap |
---|---|---|
-1.84 | $52.86M | |
-0.34 | $44.57M | |
-0.43 | $14.26M | |
-7.41 | $1.62B | |
-1.59 | $89.71M | |
-0.95 | $270.76M | |
-6.23 | $1.53B | |
-12.46 | $3.24B | |
-2.55 | $218.45M | |
-4.12 | $461.30M | |
-10.63 | $3.48B | |
-45.48 | $5.84B | |
-29.52 | $12.60B | |
-5.32 | $4.12B | |
-17.12 | $1.49B | |
-7.94 | $1.06B | |
2.07 | $5.24M | |
-10.87 | $278.69M | |
-0.78 | $30.89M | |
-0.13 | $3.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sosei Group Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sosei Group Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sosei Group Corporation's PE Ratio?
How is the PE Ratio calculated for Sosei Group Corporation (SOLTF)?
What is the highest PE Ratio for Sosei Group Corporation (SOLTF)?
What is the 3-year average PE Ratio for Sosei Group Corporation (SOLTF)?
What is the 5-year average PE Ratio for Sosei Group Corporation (SOLTF)?
How does the current PE Ratio for Sosei Group Corporation (SOLTF) compare to its historical average?